NY-ESO-1 94-102 (HLA-B35:01) (HLA-B51:01)
( MPFATPMEA )

NY-ESO-1-derived peptide of MPFATPMEA sequence covering 94-102 and HLA-B*35:01 HLA-B*51:01 molecule. The peptide NY-ESO-1 94-102 (HLA-B*35:01) (HLA-B*51:01) recognizes human CD8 T cells, and can be used in the analysis of individual antigen-specific T cells.

Sequence:	MPFATPMEA
Gene:	CTAG1A
Delivery:	3 weeks
C-Terminus:	OH
N-Terminus:	H
Amount:	1 mg
Counter Ion:	TFA
Protein:	Cancer testis antigen, NY-ESO-1
Species:	Human
Allele:	HLA-B35:01, HLA-B51:01
Application :	Flow Cytometry
Indication :	Cancer
Purity :	95% HPLC-MS

Protocols and Tips

Handling peptides

Data sheets

Safety data sheet poly peptides:

Do you have any questions concerning this product?

Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€105.00*

Prices excl. VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS

Amount in mg

1 mg

5 mg

Product number: EP11376_1

More NY-ESO-1 peptides

NY-ESO-1 108–116 (HLA-A*02:01) ( SLAQDAPPL )

From €105.00*

Details

NY-ESO-1 127-136 (HLA-A*68:01) ( TVSGNILTIR )

From €105.00*

Details

NY-ESO-1 153-170 (HLA-B*15:17) ( ITQCFLPVF )

From €105.00*

Details

NY-ESO-1 157-165 (HLA-A*02:01) ( SLLMWITQV )

NY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells SLLMWITQV is a linear peptidic epitope (epitope ID59283) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assaysNY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells

From €105.00*

Details

NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C ( SLLMWITQC )

SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays Antigen Peptide NY-ESO-1 157-165 (9C) (HLA-A*02:01) SLLMWITQC for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*

Details

NY-ESO-1 158-166 (HLA-A*24:02) ( LLMWITQCF )

NY-ESO-1 158-166 (HLA-A*24:02) peptide LLMWITQCF for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells. LLMWITQCF is a linear peptidic epitope studied as part of Other Homo sapiens (human) protein from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays.

From €105.00*

Details

NY-ESO-1 86-94 (HLA-A*02:01) ( RLLEFYLAM )

From €105.00*

Details

NY-ESO-1 93-101 (HLA-B*07:02) ( AMPFATPME )

From €105.00*

Details

NY-ESO-1 94-102 (HLA-B*35:01) (HLA-B*51:01) ( MPFATPMEA )

From €105.00*

Details

NY-ESO-1 Peptide Pool, human

Pool of 43 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Cancer/testis antigen 1 (NY-ESO-1) (UniProt-ID: P78358) of Homo sapiens (Human) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.You can find applications and references in our blog post: Esophagogastric adenocarcinoma: Tumor-associated antigens, immune responses and HLA-I Expression

€237.50*

NY-ESO-1_LAGE-2 91-101 (HLA-A*24:02) ( YLAMPFATPME )

From €106.60*

Details

NY-ESO1 Sub Peptide Pool (>95% HPLC)

This eptide pool consists of 9 overlapping peptides, from a peptide scan through human Cancer/testis antigen 1 (NY-ESO-1; UniProt ID: P78358).

€138.20*

Request a Quotation

Your Contact Information

Quotation Sent!

NY-ESO-1 94-102 (HLA-B35:01) (HLA-B51:01)
( MPFATPMEA )